Tumörer. : Devita, Hellman, and Rosenberg's cancer : principles & practice of oncology / editors, Vincent T. DeVita, Jr., Theodore S. Lawrence, Steven A. Rosenberg ; with 404 contributing authors
2015
1
Tumorhemmung : Tumor-suppressing viruses, genes, and drugs : innovative cancer therapy approaches / edited by Hiroshi Maruta
The phenomenon of target cell destruction by immunologically active effector cells. It may be brought about directly by sensitized T-lymphocytes or by lymphoid or myeloid "killer" cells, or it may be mediated by cytotoxic antibody, cytotoxic factor released by lymphoid cells, or complement
The phenomenon of target cell destruction by immunologically active effector cells. It may be brought about directly by sensitized T-lymphocytes or by lymphoid or myeloid "killer" cells, or it may be mediated by cytotoxic antibody, cytotoxic factor released by lymphoid cells, or complement
The origin, production or development of cancer through genotypic and phenotypic changes which upset the normal balance between cell proliferation and cell death. Carcinogenesis generally requires a constellation of steps, which may occur quickly or over a period of many years
Cell changes manifested by escape from control mechanisms, increased growth potential, alterations in the cell surface, karyotypic abnormalities, morphological and biochemical deviations from the norm, and other attributes conferring the ability to invade, metastasize, and kill
Cell changes manifested by escape from control mechanisms, increased growth potential, alterations in the cell surface, karyotypic abnormalities, morphological and biochemical deviations from the norm, and other attributes conferring the ability to invade, metastasize, and kill
Tests to experimentally measure the tumor-producing/cancer cell-producing potency of an agent by administering the agent (e.g., benzanthracenes) and observing the quantity of tumors or the cell transformation developed over a given period of time. The carcinogenicity value is usually measured as milligrams of agent administered per tumor developed. Though this test differs from the DNA-repair and bacterial microsome MUTAGENICITY TESTS, researchers often attempt to correlate the finding of carcinogenicity values and mutagenicity values
Tests to experimentally measure the tumor-producing/cancer cell-producing potency of an agent by administering the agent (e.g., benzanthracenes) and observing the quantity of tumors or the cell transformation developed over a given period of time. The carcinogenicity value is usually measured as milligrams of agent administered per tumor developed. Though this test differs from the DNA-repair and bacterial microsome MUTAGENICITY TESTS, researchers often attempt to correlate the finding of carcinogenicity values and mutagenicity values
1
Tumorimmunologie : Cancer vaccines and tumor immunity / [edited by] Rimas Orentas, James W. Hodge, Bryon D. Johnson
2008
1
Tumorinduktion : Cancer stem cells : methods and protocols / edited by John S. Yu
Tumors -- Alternative treatment : Alternating electric fields therapy in oncology : a practical guide to clinical applications of tumor treating fields / Eric T. Wong, editor
Tumors -- Biopsy : Small volume biopsy in pediatric tumors : an atlas for diagnostic pathology / Jerzy Klijanienko, Živa Pohar Marinšek, Henryk A. Domanski, editors
Bladder -- Tumors. : Bladder tumors : molecular aspects and clinical management / Vinata B. Lokeshwar, Axel S. Merseburger, Stefan H. Hautmann, editors
Blood-vessels -- Tumors -- Atlases : Hemangiomas and vascular malformations : an atlas of diagnosis and treatment / Raul Mattassi, Dirk A. Loose, Massimo Vaghi, editors ; foreword by J. Leonel Villavicencio
